Sputnikv Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Scientists around the world think the published information on Russia’s Sputnik V Covid-19 vaccine may be too good to be true.

Sputnik V Arrives In India: Phase 3 Trial Clear & Transparent, Claim Russian Scientists Sputnik V Arrives In India: Phase 3 Trial Clear & Transparent, Claim Russian Scientists Credit: Reuters News Highlights “Around 216 crore doses of vaccines will be manufactured in India between August-December" New Delhi/Bhubaneswar: NITI Aayog Member (Health), Dr VK Paul on Thursday announced that Russian COVID-19 vaccine- Sputnik V has arrived in India. Sputnik V production will begin in July and it is estimated that 15.6 crore doses will be manufactured,” said Dr VK Paul, NITI Aayog Member (Health)....

Follow RT on Russia’s Sputnik V coronavirus vaccine is expected to have a prolonged immunization effect, providing protection against the deadly disease for at least two years, the formula's developer told journalists, on Tuesday. The estimated duration of the vaccine's effects was revealed by Alexander Gintsburg, the head of the Gamaleya Research Institute of Epidemiology and Microbiology, which developed Russia's pioneering Sputnik V vaccine. We hold very high hopes, backed by the facts already collected experimentally, that the duration of the vaccine's effect... will last not se...

Pfizer's COVID-19 vaccine deliveries to Bahrain delayed The small island state of Bahrain has the third-highest rate of vaccinations per capita in the world so far, according to the Our World in Data website, which is run by an Oxford University research programme Reuters | January 16, 2021 | Updated 14:57 IST A January shipment of the Pfizer-BioNTech vaccine to the Gulf state of Bahrain will not arrive on time, the ministry of health said on Saturday, but second doses of the jab already scheduled will not be affected. The small island state of Bahrain has the third-highest rate of vaccinat...

Indian pharma industry rose to occasion during coronavirus pandemic: Dr Reddy's Chairman Satish Reddy Speaking at the 25th Wharton India Economic Forum, he said the Indian pharma industry ensured the continuity of supplies PTI | February 14, 2021 | Updated 12:54 IST Talking about the opportunities provided by COVID-19, Reddy said that when it came to therapeutics, Indian companies have risen to the occasion, they did it by re-purposing the drugs The Indian pharma industry has risen to the occasion and has made efforts to ensure that medicines and vaccines reach people during the pandemic, Dr...